PT  - JOURNAL ARTICLE
AU  - Buckley, Rita
ED  - Apovian, Caroline M.
TI  - FDA Opens Door to Obesity Pharmacotherapy
DP  - 2013 Nov 01
TA  - MD Conference Express
PG  - 14--15
VI  - 13
IP  - 10
4099  - http://mdc.sagepub.com/content/13/10/14.short
4100  - http://mdc.sagepub.com/content/13/10/14.full
AB  - Obesity drugs have eluded the United States Food and Drug Administration (FDA) approval process for 13 years, but with mechanisms of action identified and obesity recognized as a disease, that is changing. This article reviews the history of obesity pharmacology, present options in obesity pharmacotherapy, as well as the discovery of peptide-based mixed agonists based on glucagon.